PTPRK can directly dephosphorylate EGFR during both basal- and ligand-stimulated EGFR phosphorylation, and it can contribute to tumor suppression through its negative regulation of EGFR signaling [58,59,60]. This evidence concerns the gene PTPRK and neoplasm.